Mobile

A Phase 1/2 Dose Escalation Study of TRU-015 in Subjects with Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma

Update Il y a 4 ans
Reference: EUCTR2006-006413-33

Woman and Man

  • | Country :
    • -
  • | organs :
    • -
  • | Specialty :
    • -

Extract

To evaluate the safety and to determine the maximum tolerated dose (MTD), if reached, of TRU 015 in subjects with relapsed or refractory B cell NHL.

Inclusion criteria

  • Relapsed or Refractory B-Cell Non-Hodgkin’s Lymphoma

Links